MyAverix Finance
F · Healthcare
HN30 (HN30)
Biotechnology
HN30 (HN30) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $2.53M, P/E ratio is 18.00, net margin is 0.0%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for HN30
HN30 (HN30) — FAQ
What is HN30's market cap?
HN30 (HN30) has a reported market cap of $2.53M (data as of 2026-03-29).
What is HN30's P/E ratio?
The price-to-earnings (P/E) ratio for HN30 (HN30) is 18.00 (data as of 2026-03-29).
Does HN30 pay a dividend?
Dividend yield is not available in the current snapshot for HN30 (HN30). Check the MyAverix Finance app for the latest dividend data.
What sector is HN30 in?
HN30 (HN30) is classified in the Healthcare sector (Biotechnology industry).
What exchange is HN30 listed on?
HN30 is listed on F.
What is HN30's net margin?
HN30 (HN30) reports a net margin of 0.0% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.